GLGi: Emerging Therapies for Prostate Cancer
Time & Location
Originally Presented: April 10, 2007Presenter(s):
GLG Expert Contributor
Agenda:
- Experimental and molecular therapeutic agents
- Novel agents in the developmental pipeline for prostate cancer
- Small molecule kinase inhibitors: MEK, Raf, and Hsp90
Learn More About GLG Institute
About GLG InstituteSM Seminars
A program focused on educating business and investment professionals through seminars on current trends and core concepts in various industries. Detailed workbooks distributed at the Seminars provide educational reference materials for later review. The GLG institute website. www.glginstitute.com, enables clients to increase thier own industry education by proposing new seminar topics or adding agenda terms to currently scheduled seminars.


